Cart
sales@molnova.com
SU5204
CAS No. 186611-11-0
SU5204( 3-[(2-Ethoxyphenyl)methylidene]-1H-indol-2-one )
Catalog No. M22955 CAS No. 186611-11-0
SU5204, an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and HER2).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 46 | In Stock |
|
| 10MG | 67 | In Stock |
|
| 25MG | 119 | In Stock |
|
| 50MG | 177 | In Stock |
|
| 100MG | 284 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSU5204
-
NoteResearch use only, not for human use.
-
Brief DescriptionSU5204, an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and HER2).
-
DescriptionSU5204, an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and HER2).
-
In Vitro——
-
In Vivo——
-
Synonyms3-[(2-Ethoxyphenyl)methylidene]-1H-indol-2-one
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorVEGFR2|HER2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number186611-11-0
-
Formula Weight265.31
-
Molecular FormulaC17H15NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (376.92 mM)
-
SMILESO=C1NC2=C(C=CC=C2)/C1=C/C3=CC=CC=C3OCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Peng Cho Tang, et al. 3-heteroaryl-2-indolinone compounds for the treatment of disease. US5792783A.
molnova catalog
related products
-
Telatinib
An orally active, small molecule inhibitor of VEGFR-2 (IC50=6 nM), VEGFR-3 (IC50=4 nM), PDEGFRα (IC50=15 nM) and c-Kit (IC50=1 nM) in biochemical assays.
-
TG 100572 Hydrochlor...
TG 100572 Hydrochloride is a inhibitor of multi-targeted kinase which inhibits receptor tyrosine kinases and Src kinases.
-
Bucillamine
Bucillamine protects against Ischemia/reperfusion injury in high-risk organ transplants and inhibits the production of VEGF.
